UM researchers have developed a deep learning model to predict compound protein interactions. GraphBAN is an inductive ...

Recuresion Pharma (RXRX) stock and other AI-driven biotechs surge as FDA embraces computational models over animal testing ...

Schrödinger’s stock surged after the FDA's initiative to phase out animal testing, benefiting its computational drug ...

On new antibiotic medicine tested by Wockhart, Wockhart Limited Executive Director Dr. Huzaifa Khorakiwala said, “Our ...

PRISM BioLab, Co. Ltd. ("PRISM BioLab"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced ...

The development and spread of antibiotic resistance represents one of the greatest threats to global health. To overcome ...

The development of new antibiotics to treat superbugs and other bacterial infections is a global priority, with the rate of infections that cannot be treated with current antibiotics rising and ...

Michelle Xia represents a rising generation of biotech companies in China challenging Western giants.

However, it's possible that other drugmakers could be more interested in teaming up with Recursion with the FDA promoting the ...

The Institute of Cancer Research, London, which helped develop the drug, welcomed the move. A twice-a-day pill for the most ...

Two South African men, aged between 24 and 39, were arrested following the discovery of yet another drug laboratory in ...